Clinical Trials Directory

Trials / Completed

CompletedNCT01263561

Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
University of Toronto · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Prospective randomized study comparing guarded Ex-PRESS to trabeculectomy. Primary outcome: IOP and success (complete success defined as IOP between 5-18 mmHg and 20% reduction from baseline without medication or additional glaucoma surgery and qualified success defined as IOP between 5-18 mmHg and 20% reduction from baseline with or without glaucoma medication but no additional glaucoma surgery). Secondary outcomes: number of glaucoma medications, visual acuity, number of complications, corneal pachymetry and corneal endothelial cell counts.

Detailed description

Complications will be evaluated for the intra-operative, early post-operative (up until 1 month) and late post-operative (from 1 month to 1 year) periods. In addition complications will be evaluated as severe (defined as a permanent reduction in vision or complications requiring a surgical intervention) and not severe (complications which resolve with conservative management). As an individual subject may have more than one complication, the number of complications will be compared between the two surgical groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREExPRESS shuntExPRESS miniature glaucoma drainage device
PROCEDUREtrabeculectomytrabeculectomy filtering surgery

Timeline

Start date
2009-04-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2010-12-20
Last updated
2014-12-09
Results posted
2014-12-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01263561. Inclusion in this directory is not an endorsement.